NFKB1 and hepatocellular carcinoma: Studies by Balkwill [28], Ringelhan et al. [29], and Taniguchi et al. [30] reported that TNFα activated the NF-κB signaling pathway, contributing to the promotion and progression of human HCC through hepatic inflammation, hepatocyte death, and compensatory proliferation.